These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29054584)

  • 1. [Abnormal hair].
    Coen M; Cramer B; Serratrice J
    Rev Med Interne; 2019 Feb; 40(2):134-135. PubMed ID: 29054584
    [No Abstract]   [Full Text] [Related]  

  • 2. Eyelashes depigmentation following treatment with pazopanib for metastatic renal cell carcinoma.
    Vaccaro M; Riso G; Altavilla D; Cannavò SP
    Dermatol Ther; 2019 Nov; 32(6):e13140. PubMed ID: 31664777
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversible hair depigmentation in a Japanese female treated with pazopanib.
    Kobayashi E; Koyama T; Kobayashi K; Setsu N; Kawashima M; Kawai A
    J Dermatol; 2014 Nov; 41(11):1021-2. PubMed ID: 25346306
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid hair depigmentation in patient treated with pazopanib.
    Šeparović R; Pavlović M; Silovski T; Tečić Vuger A
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30139781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinoma.
    Sternberg CN; Davis ID; Deen KC; Sigal E; Hawkins RE
    Oncology; 2014; 87(6):342-50. PubMed ID: 25227656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Distinctive Hair Changes Associated With Pazopanib in Patients With Renal Cell Carcinoma (RCC) Versus Patients Without RCC: A Comparative Systematic Review and Meta-analysis.
    Elhalawani H; Heiba M; Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Jun; 15(3):e325-e335. PubMed ID: 28189432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen-induced hair colour change.
    Hampson JP; Donnelly A; Lewis-Jones MS; Pye JK
    Br J Dermatol; 1995 Mar; 132(3):483-4. PubMed ID: 7718473
    [No Abstract]   [Full Text] [Related]  

  • 8. Probable iatrogenic xanthotrichia.
    Martí Fajardo N; García Llopis P; Ibáñez Ramón R; Ortega Monzó C
    Actas Dermosifiliogr; 2014 Sep; 105(7):722-3. PubMed ID: 25181953
    [No Abstract]   [Full Text] [Related]  

  • 9. Hair depigmentation during chemotherapy with a class III/V receptor tyrosine kinase inhibitor.
    Routhouska S; Gilliam AC; Mirmirani P
    Arch Dermatol; 2006 Nov; 142(11):1477-9. PubMed ID: 17116839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hair graying and loss induced by imatinib mesylate.
    Yun SK; Song KH; Hwang SR; Kim HU; Lee NR; Park J
    J Dermatol; 2014 Jan; 41(1):107-8. PubMed ID: 24354806
    [No Abstract]   [Full Text] [Related]  

  • 11. A rare case: Hallucination associated with pazopanib.
    Demirci NS; Erdem GU; Dogan M; Ozdemir NY; Zengin N
    J Cancer Res Ther; 2015; 11(4):961-2. PubMed ID: 26881556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible hair depigmentation in a patient treated with imatinib.
    Mariani S; Abruzzese E; Basciani S; Fiore D; Persichetti A; Watanabe M; Spera G; Gnessi L
    Leuk Res; 2011 Jun; 35(6):e64-6. PubMed ID: 21176848
    [No Abstract]   [Full Text] [Related]  

  • 13. Pazopanib for the treatment of metastatic renal cell carcinoma.
    Pick AM; Nystrom KK
    Clin Ther; 2012 Mar; 34(3):511-20. PubMed ID: 22341567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A-induced hair darkening.
    Rebora A; Delmonte S; Parodi A
    Int J Dermatol; 1999 Mar; 38(3):229-30. PubMed ID: 10208625
    [No Abstract]   [Full Text] [Related]  

  • 15. Benefits of pazopanib over sunitinib for renal cell carcinoma.
    Granovetter M
    Lancet Oncol; 2016 Mar; 17(3):e93. PubMed ID: 26853821
    [No Abstract]   [Full Text] [Related]  

  • 16. A teenage girl with green hair.
    Schwartz RH; Yasin SK; Yoo JK
    Pediatr Dermatol; 2014; 31(4):497-9. PubMed ID: 25039704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pazopanib for treatment of renal cell carcinoma and soft tissue sarcomas].
    Brotelle T; Bay JO
    Bull Cancer; 2014 Jun; 101(6):641-6. PubMed ID: 24977453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pazopanib-related tumor lysis syndrome in metastatic clear cell renal cell carcinoma: a case report.
    van Kalleveen MW; Walraven M; Hendriks MP
    Invest New Drugs; 2018 Jun; 36(3):513-516. PubMed ID: 29464464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of multikinase inhibitors in metastatic renal cell carcinoma and indirect treatment comparisons.
    Catalá-López F
    Eur J Cancer; 2013 Mar; 49(4):984-5. PubMed ID: 23140823
    [No Abstract]   [Full Text] [Related]  

  • 20. Green hair.
    Mascaró JM; Ferrando J; Fontarnau R; Torras H; Domínguez A; Mascaró JM
    Cutis; 1995 Jul; 56(1):37-40. PubMed ID: 7555100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.